Compliance and regulatory considerations for the implementation of the multi-attribute-method by mass spectrometry in a quality control laboratory.

Multi-attribute methods employing mass spectrometry are applied throughout the biopharmaceutical industry for product and process characterization purposes but are not yet widely accepted as a method for batch release and stability testing under the good manufacturing practice (GMP) regime, due to limited experience and level of comfort with the technical, compliance and regulatory aspects of its implementation at quality control (QC) laboratories. This article is the second part of a two-tiered publication aiming at providing guidance for implementation of the multi-attribute method by peptide mapping liquid chromatography mass spectrometry (MAM) in a QC laboratory. The first part [1] focuses on technical considerations, while this second part provides considerations related to GMP compliance and regulatory aspects. This publication has been prepared by a group of industry experts representing 14 globally acting major biotechnology companies under the umbrella of the European Federation of Pharmaceutical Industries and Associations (EFPIA) Manufacturing & Quality Expert Group (MQEG).

Technical considerations for the implementation of the multi-attribute-method by mass spectrometry in a quality control laboratory.

Multi-attribute methods employing mass spectrometry are applied throughout the biopharmaceutical industry for product and process characterization purposes but are not yet widely accepted as a method for batch release and stability testing under good manufacturing practice (GMP) due to limited experience and level of comfort with the technical, compliance and regulatory aspects of its implementation at quality control (QC) laboratories. Here, current literature related to the development and application of the multi-attribute method by peptide mapping liquid chromatography mass spectrometry (MAM) is compiled with the aim of providing guidance for the implementation of MAM in a QC laboratory. This article, focusing on technical considerations, is the first part of a two-tiered publication, whereby the second part will focus on GMP compliance and regulatory aspects. This publication has been prepared by a group of industry experts representing 14 globally acting major biotechnology companies under the umbrella of the European Federation of Pharmaceutical Industries and Associations (EFPIA) Manufacturing & Quality Expert Group (MQEG).

Computational and Experimental Studies of Regioselective SNAr Halide Exchange (Halex) Reactions of Pentachloropyridine.

The Halex reaction of pentachloropyridine with fluoride ion was studied experimentally and computationally with a modified ab initio G3MP2B3 method. The G3 procedure was altered, as the anionic transition state optimizations failed due to the lack of diffuse functions in the small 6-31G* basis set. Experimental Halex regioselectivities were consistent with kinetic control at the 4-position. The reverse Halex reaction of fluoropyridines with chloride sources was demonstrated using precipitation of LiF in DMSO as a driving force. Reverse Halex regioselectivity at the 4-position was predicted by computations and was consistent with kinetic control. Scrambling of halide ions between chlorofluoropyridines was catalyzed by n-Bu4PCl, and the products of these reactions were shown to result from a combination of kinetic and thermodynamic control. Comparison of the C-F and C-Cl homolytic bond dissociation energies suggests that an important thermodynamic factor which controls regioselectivity in this system is the weak C2-Cl bond. The differences between ΔH° values of chlorofluoropyridines can be explained by a combination of three factors: (1) the number of fluorine atoms in the molecule, (2) the number of fluorine atoms at the C2 and C6 positions, and (3) the number of pairs of fluorine atoms which are ortho to one another.

Solvation parameter models for retention on perfluorinated and fluorinated low temperature glassy carbon stationary phases in reversed-phase liquid chromatography.

The retention of solutes on two fluorinated low temperature glassy carbon (F-LTGC) stationary phases under reversed-phase liquid chromatographic conditions was studied by employing the solvation parameter model. The two fluorinated glassy carbon stationary phases were produced by slowly heating zirconia particles that were encapsulated with oligo[1,3-dibutadiyne-1,3-(tetrafluoro)phenylene] precursor polymer to two different final temperatures (200 and 400 degrees C). The resulting carbon particles had different amounts of fluorine after thermal processing. The solvation parameter models indicated that different intermolecular interactions are important in describing retention on the two stationary phases. The interactions that are important for describing retention on the 200 degrees C processed F-LTGC stationary phase are hydrogen bond basicity> or =dispersion>hydrogen bond acidity>dipolarity/polarizability. The interactions that describe the retention on the 400 degrees C processed F-LTGC are hydrogen bond basicity>dispersion>excess molar refraction> or =hydrogen bond acidity. The solvation parameter model for the 200 degrees C processed F-LTGC showed similar trends in the relative importance of intermolecular interactions as previously found for octadecyl-polysiloxane stationary phases, while the 400 degrees C processed F-LTGC had similar intermolecular interactions with solutes as found with porous glassy carbon in that pi-pi interactions with the carbon surface contribute more so to the retention.